| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/19/2023 | Akero Therapeutics, Inc. | AKRO | Purchase | Common Stock | 400k | $26.00 | $10.4M | See Footnote | 09/19/2022 |
| 08/08/2023 | Akero Therapeutics, Inc. | AKRO | Purchase | Common Stock | 25k | $42.06 | $1.1M | See Footnote | 08/08/2023 |
| 05/19/2023 | Akero Therapeutics, Inc. | AKRO | Purchase | Common Stock | 120k | $42.00 | $5M | See Footnote | 09/19/2022 |
| 05/19/2023 | Akero Therapeutics, Inc. | AKRO | Purchase | Common Stock | 120k | $42.00 | $5M | See Footnote | 09/19/2022 |
| 09/19/2022 | Akero Therapeutics, Inc. | AKRO | Purchase | Common Stock | 400k | $26.00 | $10.4M | See Footnote | 09/19/2022 |
| 06/17/2022 | Olema Pharmaceuticals, Inc. | OLMA | Grant | Stock Option (right to buy) | 21.5k | $0.00 | $0 | | 06/17/2022 |
| 06/16/2022 | Olema Pharmaceuticals, Inc. | OLMA | Grant | Stock Option (right to buy) | 21.5k | $3.43 | $73.8k | | 06/16/2022 |
| 06/02/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 15k | $8.13 | $122k | | 06/02/2022 |
| 06/11/2021 | ALX ONCOLOGY HOLDINGS INC | ALXO | Grant | Stock option (right to buy) | 12k | $59.66 | $716.2k | | 06/11/2021 |
| 06/09/2021 | Olema Pharmaceuticals, Inc. | OLMA | Grant | Stock Option (right to buy) | 21.5k | $27.66 | $595.2k | | 06/09/2021 |
| 06/01/2021 | Akero Therapeutics, Inc. | AKRO | Gift | Stock Option (Right to Buy) | 13k | $25.20 | $327.6k | | 06/01/2021 |
| 06/01/2021 | Akero Therapeutics, Inc. | AKRO | Gift | Stock Option (Right to Buy) | 23.8k | $19.97 | $475.9k | | 06/01/2021 |
| 06/01/2021 | Akero Therapeutics, Inc. | AKRO | Gift | Stock Option (Right to Buy) | 13k | $26.32 | $342.2k | | 06/01/2021 |
| 06/01/2021 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 13k | $26.32 | $342.2k | | 06/01/2021 |
| 12/14/2020 | ALX ONCOLOGY HOLDINGS INC | ALXO | Purchase | Common Stock | 20k | $76.00 | $1.5M | See footnote | 12/14/2020 |
| 11/23/2020 | Olema Pharmaceuticals, Inc. | OLMA | Conversion | Series C Convertible Preferred Stock | 1.2M | $0.00 | $0 | See Footnote | 11/23/2020 |
| 11/23/2020 | Olema Pharmaceuticals, Inc. | OLMA | Conversion | Series B Convertible Preferred Stock | 1.4M | $0.00 | $0 | See Footnote | 11/23/2020 |
| 11/23/2020 | Olema Pharmaceuticals, Inc. | OLMA | Purchase | Common Stock | 1.2M | $19.00 | $22M | See Footnote | 11/23/2020 |
| 11/23/2020 | Olema Pharmaceuticals, Inc. | OLMA | Conversion | Common Stock | 1.2M | $0.00 | $0 | See Footnote | 11/23/2020 |
| 11/23/2020 | Olema Pharmaceuticals, Inc. | OLMA | Conversion | Common Stock | 1.4M | $0.00 | $0 | See Footnote | 11/23/2020 |
| 11/18/2020 | Olema Pharmaceuticals, Inc. | OLMA | Grant | Stock Option (Right to Buy) | 21.5k | $19.00 | $408.9k | | 06/01/2020 |
| 09/30/2020 | Olema Pharmaceuticals, Inc. | OLMA | Purchase | Series C Convertible Preferred Stock | 1.2M | $11.06 | $13.1M | See Footnote | 06/01/2020 |
| 07/21/2020 | ALX ONCOLOGY HOLDINGS INC | ALXO | Conversion | Common Stock | 2.1M | $0.00 | $0 | See footnote | 07/21/2020 |
| 07/21/2020 | ALX ONCOLOGY HOLDINGS INC | ALXO | Purchase | Common Stock | 975k | $19.00 | $18.5M | See footnote | 07/21/2020 |
| 07/21/2020 | ALX ONCOLOGY HOLDINGS INC | ALXO | Conversion | Series C Convertible Preferred Stock | 2.1M | $0.00 | $0 | See footnote | 07/21/2020 |
| 07/16/2020 | ALX ONCOLOGY HOLDINGS INC | ALXO | Grant | Stock Option (right to buy) | 24k | $19.00 | $456.2k | | 07/16/2020 |
| 06/01/2020 | Olema Pharmaceuticals, Inc. | OLMA | Purchase | Series B Convertible Preferred Stock | 339.6k | $4.71 | $1.6M | See Footnote | 06/01/2020 |
| 06/01/2020 | Olema Pharmaceuticals, Inc. | OLMA | Purchase | Series B Convertible Preferred Stock | 339.6k | $4.71 | $1.6M | See Footnote | 06/01/2020 |
| 06/01/2020 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 13k | $25.20 | $327.6k | | 06/01/2020 |
| 03/30/2020 | Akero Therapeutics, Inc. | AKRO | Exercise | Common Stock | 2.2k | $19.97 | $43.3k | | 03/30/2020 |
| 11/08/2019 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 2.2k | $19.97 | $43.3k | | 03/30/2020 |
| 11/08/2019 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 26k | $19.97 | $519.2k | | 11/08/2019 |